Close

Baird Downgrades Pharmasset (VRUS) to Neutral; Sticking with INHX on Derivative Weakness Dec 16, 2011 10:56AM
Baird Maintains an 'Outperform' on Pharmasset (VRUS); First Impression: Positive for Both Companies and the Space Nov 21, 2011 11:01AM
Buy Pharmasset (VRUS) on Ambitious Phase 3 Program for '7977 - Baird Nov 1, 2011 11:14AM
Baird Maintains an 'Outperform' on Pharmasset (VRUS); Delivering the Goods; Excellent SVR12 for '7977 Sep 6, 2011 10:12AM
Baird Reiterates an 'Outperform' on Pharmasset (VRUS); Makes TMC435 One of the Cool Kids Jul 6, 2011 10:20AM


Feb 9, 2011 07:04AM Baird Reiterates an 'Outperform' on Pharmasset (VRUS); Raising PT On Our Top Mid-Cap Pick
Jan 6, 2011 09:43AM Baird reiterates an 'Outperform' on Pharmasset (VRUS); Another Positive Update on Wholly-Owned Assets '7977 and '938
Nov 24, 2010 08:39AM Baird Analyst Continues to Recommend Shares of Pharmasset (VRUS); Company Remains in Catalyst-Rich, Potentially Value-Creating Period
Jun 9, 2010 11:50AM Baird Says Pharmasset (VVUS) R7128 AASLD Abstract Reinforces Thesis
May 18, 2010 08:36AM Pharmasset (VRUS) Announces Exercise of Underwriters' Overallotment Option
May 18, 2010 07:18AM Pharmasset (VRUS) Announces Exercise of Overallotment in 3.2M Common Offering
May 14, 2010 07:04AM Pharmasset (VRUS) Prices 3.2M Common Offering at $29.00/Share
Nov 3, 2009 10:14AM Baird Maintains an 'Outperform' on Pharmasset (VRUS); Year Ahead is Catalyst-Rich
Sep 8, 2009 08:24AM Baird upgrades Pharmasset (VRUS) to Outperform
Apr 16, 2008 09:04AM Color on Baird Coverage of Pharmasset (VRUS)
Apr 16, 2008 07:38AM Baird Initiates Coverage on Pharmasset (VRUS) with a Neutral